Wilson Sonsini Goodrich & Rosati’s legacy closely traces the birth and evolution of Silicon Valley.
For nearly six decades, Wilson Sonsini has represented the technology pioneers associated with virtually every milestone innovation.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle
CAREERS
We look for the best and
brightest of tomorrow
and develop careers
from the ground up.
Wilson Sonsini Introduces Digital Hub for Emerging Companies Practice Serving the Next Generation of Founders, Entrepreneurs, and Venture Capitalists >
ALERTS
Delaware Court of
Chancery Issues
Additional Guidance on
Busted Deals>
ALERTS
Are Online Marketplaces
Liable for product
Defects? California says
Yes>
ALERTS
News and Featured Insights
Leading Matters
A
CLIENT HIGHLIGHTS
Wilson Sonsini Advises
Capsigen on IP Matters
Related to Colaboration
with Biogen
On May 10, 2021, Biogen Inc. and
Capsigen Inc. announced they have
entered into a strategic research
collaboration to engineer novel adeno-
associate virus (AAV) capsids that ha…
LEARN MORE >
A
On May 4, 2021, San Francisco based-
Day 1 Biopharmaceuticals, a Phase 2
biotech developing treatments for
pediatric glioma and other cancers, filed
with the SEC to raise up to $100 Million…
CLIENT HIGHLIGHTS
Wilson Sonsini Advices
Day One on IP Matters
Related to IPO
LEARN MORE >
A
LEARN MORE >
CLIENT HIGHLIGHTS
Wilson Sonsini Advises
Recursion on $501 Million
IPO
On April 20, 2021, Recursion
Pharmaceuticals, Inc., of salt lake city
announced the closing of its initial
public offering of 27,878,787 shares of its
Class A common Stock, Which includes…
A
CLIENT HIGHLIGHTS
Firm Advises Sonder on
Business combination
with Gores Metropoulos
||SPAC
On April 30, 2021, Sonder Holdings, a
leading next-generation hospitality
company that is redefining the guest
experience, and Gores Metropoulos ||,
Inc., a Special purpose acquisition…
LEARN MORE >
A
LEARN MORE >
CLIENT HIGHLIGHTS
Wilson Sonsini Advises
ceribell on $53 Million
Series C Financing
On April 29, 2021, ceribell innovator of
the Rapid Response EEG, a novel non-
invasive brain monitor, announced the
completion of a $53 million series C
financing, Which was co-led by…
A
CLIENT HIGHLIGHTS
Wilson Sonsini Advises
Amply on IP Matters
Related to Acquisition by
Pfizer
On April 28, 2021, Pfizer Inc. announce
that it has acquired Amplyx
Pharmaceuticals, Inc., a privately-held
company dedicated to the development
of therapies for debilitating and life-…
LEARN MORE >
Digital Health Report – Q2 2021
In this issue, we discuss U.S. Food and Drug Administration
(FDA) regulation of wellness devices. We also look at good
commercial contracting hygiene for digital health start-ups.
Other articles include recent enforcement actions against
Electronic Health Records (EHR) technology vendors, and our
next installment on HIPAA for digital health entrepreneurs,
about proposed changes to improve individual access to PHI.
